Japan Halitosis Treatment Market Overview
As per MRFR analysis, the Japan Halitosis Treatment Market Size was estimated at 131.1 (USD Million) in 2023.The Japan Halitosis Treatment Market Industry is expected to grow from 146.7(USD Million) in 2024 to 390.8 (USD Million) by 2035. The Japan Halitosis Treatment Market CAGR (growth rate) is expected to be around 9.316% during the forecast period (2025 - 2035).
Key Japan Halitosis Treatment Market Trends Highlighted
Rising awareness of oral health and hygiene is causing clear trends in the Japan Halitosis Treatment Market. Effective halitosis remedies are in increased demand as Japanese customers become more aware of unpleasant breath. Japan's focus on personal hygiene and social graces drives this trend, as fresh breath is seen as vital for corporate environments and personal contacts. Furthermore, prompted by health-conscious behavior and a societal trend toward natural therapies, halitosis products increasingly favour natural and organic components. This trend shows a more general change in the consumer market of Japan, where people search for goods that fit their ideals about well-being and health.
Convenience for hectic lives might come from the creation of creative delivery forms such as sprays and dissolvable pills within the market. Including cutting-edge technologies, including applications tracking oral health and oral microbiome testing, might appeal to a tech-savvy audience ready for all-incompatible solutions. Aiming at producing scientifically verified solutions that boost customer confidence, recent developments reveal a rise in cooperation between dental practitioners and product producers. Moreover, an increase in e-commerce and online consulting services is changing the way patients get knowledge regarding halitosis and therapies.
As Japan keeps embracing digitization, companies that use online channels for marketing and sales may interact successfully with a larger audience, therefore transforming the halitosis difficulty into a possibility for development in this industry.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Japan Halitosis Treatment Market Drivers
Increasing Awareness Regarding Oral Hygiene
In Japan, there has been a steadily growing awareness about the importance of oral hygiene, which directly contributes to the Japan Halitosis Treatment Market Industry. As per a survey conducted by the Ministry of Health, Labour and Welfare, nearly 75% of Japanese adults are now concerned about oral health issues such as halitosis.
This increased awareness prompts consumers to seek effective treatments for bad breath, enhancing the market demand. Major dental health organizations, such as the Japan Dental Association, are playing a significant role in raising awareness through campaigns and education on maintaining proper oral hygiene.The focus on preventive care in oral health not only benefits consumers but also results in growing sales of halitosis treatment products and therapies in the region.
Rising Geriatric Population Facing Oral Health Issues
Japan’s aging population is another significant driver for the Japan Halitosis Treatment Market Industry. The Japan National Institute of Population and Social Security Research indicates that the percentage of people aged over 65 will constitute around 30% of the total population by 2035.
With aging, oral health concerns escalate, leading to increased occurrences of conditions that cause halitosis, such as gum diseases and dry mouth. Healthcare professionals, associations, and clinics are recognizing this trend and actively developing specialized treatment options, thus steering market growth.This demographic shift prompts manufacturers to innovate and tailor products catering to the unique needs of older adults, driving overall market advancements.
Technological Advancements in Halitosis Treatment
The Japan Halitosis Treatment Market Industry is witnessing rapid growth due to advancements in technology, specifically in diagnostic and treatment devices. Innovative solutions such as breath analyzers, antimicrobial therapies, and advanced oral hygiene products are gaining attention.
As per the Japan Patent Office, there has been a noticeable increase in the filing of patents related to oral health technologies, with over 150 new patents filed in just the past three years.This reflects an ongoing commitment by leading companies like Shofu and Sunstar to invest in Research and Development (R&D) to create more effective halitosis treatments. The incorporation of technology improves customer satisfaction and drives greater adoption rates, ultimately enhancing market potential in Japan.
Japan Halitosis Treatment Market Segment Insights
Halitosis Treatment Market Indication Insights
The Japan Halitosis Treatment Market is primarily segmented by indication, which plays a crucial role in addressing the diverse causes of halitosis, or bad breath. The respiratory indications tend to be significant in this market, as respiratory infections and conditions can frequently lead to unpleasant breath odors due to the accumulation of bacteria in the oral cavity and respiratory tract. Moreover, liver health is increasingly recognized for its impact on breath odor. If the liver fails to properly filter toxins from the blood, the resultant metabolic byproducts can contribute to halitosis.
Similarly, kidney health is paramount, as renal failure or dysfunction can lead to uremic breath, characterized by a distinctive ammonia-like odor. Gastrointestinal factors also play a crucial role, as digestive disorders such as gastroesophageal reflux disease can contribute to halitosis by altering the natural balance of bacteria in the mouth and throat. Systemic health issues, including many chronic diseases, can further exacerbate bad breath, highlighting the interconnectedness of oral health with overall bodily health. The market is evolving to recognize these indications, prompting advancements in treatment methods tailored specifically to address the underlying causes rather than just masking symptoms.
Additionally, public awareness regarding the implications of halitosis on social interactions and personal health is driving demand for effective treatments in Japan. As more individuals seek solutions that address specific health concerns, the market is witnessing a shift towards multifunctional products that target various underlying conditions, which signifies a growing opportunity for innovation within the halitosis treatment category in the Japan Halitosis Treatment Market.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Halitosis Treatment Market Diagnostic Tests Insights
The Japan Halitosis Treatment Market, particularly in the Diagnostic Tests segment, exhibits significant growth potential as awareness of oral health increases among the population. Diagnostic tests play a crucial role in identifying the underlying causes of halitosis, contributing to effective management of the condition. Key testing methods include Halimeter, which measures volatile sulfur compounds, and Gas Chromatography, known for its accuracy in detecting specific gases associated with bad breath.
The BANA Test focuses on specific bacteria, allowing for targeted treatments based on microbial profiles.Additionally, -Galactosidase Activity Assay offers insights into enzymatic activity related to odor production. These tests not only assist healthcare professionals in diagnosing halitosis but also empower patients with knowledge about their oral health. The increasing prevalence of oral diseases in Japan, paired with an aging population, drives demand for advanced diagnostic solutions. This market growth is further supported by the incorporation of technology and research in improving testing accuracy and patient outcomes. As a result, the segment remains a focal point of innovation within the broader Japan Halitosis Treatment Market, addressing both individual and public health concerns effectively.
Halitosis Treatment Market Drug Treatment Insights
The Drug Treatment segment within the Japan Halitosis Treatment Market is increasingly significant, driven by a growing awareness of oral hygiene and the prevalence of halitosis among different demographics in Japan. Various classifications, including Antacids, Antiseptics, Ranitidine, and others, collectively address the underlying causes of bad breath, such as gastric issues and microbial growth. Antiseptics, in particular, hold a noteworthy position due to their effectiveness in neutralizing oral pathogens and promoting a fresher breath.
Similarly, Antacids are crucial as they help manage digestive conditions that may contribute to halitosis.Ranitidine is also relevant for its role in reducing gastric acid production, thereby improving breath freshness. The rising demand for oral health products that not only mask but also treat the causes of halitosis presents a notable opportunity for growth within the industry, reflected by ongoing developments in formulation and delivery methods tailored for consumers in Japan. Market trends indicate an evolving preference toward comprehensive solutions that require minimal daily effort while ensuring sustained oral health. Thus, this segment of the Japan Halitosis Treatment Market is poised for expansion, reflecting both evolving consumer behaviors and advancements in medical insights.
Japan Halitosis Treatment Market Key Players and Competitive Insights
The Japan Halitosis Treatment Market is characterized by a growing awareness among consumers regarding oral hygiene and the adverse effects of halitosis, leading to an increase in demand for effective treatment solutions. This market landscape features a variety of product offerings, including mouthwashes, chewing gums, sprays, and various dental hygiene products, all aimed at combating bad breath. The competitive environment is shaped by both established players and newer entrants who aim to capture market share through innovative products and strategic marketing campaigns. This competitive landscape is further enriched by the involvement of health professionals and endorsement from dental associations, which help to bolster consumer confidence in the efficacy of treatment options available in the market.
Gsk Consumer Healthcare holds a significant place within the Japan Halitosis Treatment Market, leveraging its global expertise in health and wellness to introduce targeted solutions for bad breath. The company benefits from a strong brand reputation, which is built on quality and consumer trust, allowing it to maintain a competitive edge. Gsk Consumer Healthcare possesses a robust distribution network that ensures a wide availability of its products across various retail platforms, including pharmacies, grocery stores, and online channels. The existing product portfolio includes advanced toothpaste formulas and mouth rinses designed to effectively combat halitosis while promoting overall oral health. Furthermore, the company invests in marketing and educational initiatives, emphasizing the importance of regular dental care and encouraging proactive consumer engagement.
Rakuten is another key player in the Japan Halitosis Treatment Market, which capitalizes on its extensive e-commerce platform to offer a diverse array of oral care products aimed at addressing halitosis. The company has established itself as a prominent marketplace for consumers seeking effective and innovative solutions for bad breath, encompassing not only local brands but also international offerings. Rakuten's strengths lie in its vast online presence and its ability to connect consumers with a wide variety of products from multiple manufacturers.
By enabling easy access to customer reviews and ratings, Rakuten enhances consumer decision-making, fostering greater trust in their purchase choices. Additionally, Rakuten has engaged in strategic alliances and partnerships to bolster its product range and has explored acquisitions to enhance its market presence within the oral care segment. These efforts reflect a strong commitment to addressing the needs of consumers dealing with halitosis in the Japanese market.
Key Companies in the Japan Halitosis Treatment Market Include:
- Gsk Consumer Healthcare
- Rakuten
- Takeda Pharmaceutical
- Sunstar
- Daiichi Sankyo
- Mitsubishi Tanabe Pharma
- Unicharm Corporation
- ColgatePalmolive
- Procter & Gamble
- Kao Corporation
- Mitsuya
- Shiseido
- Lion Corporation
- Johnson & Johnson
- Amway
Japan Halitosis Treatment Market Industry Developments
Recent developments in the Japan Halitosis Treatment Market indicate a growing focus on innovative products and therapies. Companies like GSK Consumer Healthcare have been expanding their range of oral care products tailored to counter halitosis. Takeda Pharmaceutical and Sunstar are investing in Research and Development to improve the effectiveness of their treatments while ensuring consumer safety.
In terms of acquisitions, Johnson and Johnson has recently acquired a smaller company specializing in halitosis solutions, further strengthening their position in the market as of May 2023. Additionally, the government of Japan is increasingly prioritizing oral health, leading to a surge in public awareness campaigns about halitosis and its treatments. This has subsequently contributed to a favorable market environment.
The market valuation for companies like Colgate-Palmolive and Procter and Gamble is witnessing positive growth as consumer demand for effective halitosis treatments rises. In the past few years, significant mergers including Lion Corporation's acquisition of a niche brand in the oral care space in January 2022 have also played a crucial role in reshaping the competitive landscape of the halitosis treatment sector in Japan.
Japan Halitosis Treatment Market Segmentation Insights
Halitosis Treatment Market Indication Outlook
- Respiratory
- Liver
- Kidney
- Gastrointestinal
- Systemic
- Others
Halitosis Treatment Market Diagnostic Tests Outlook
- Halimeter
- Gas Chromatography
- BANA Test
- -Galactosidase Activity Assay
- Others
Halitosis Treatment Market Drug Treatment Outlook
- Antacids
- Antiseptics
- Ranitidine
- Others
Â
Report Attribute/Metric Source: |
Details |
MARKET SIZE 2023 |
131.1(USD Million) |
MARKET SIZE 2024 |
146.7(USD Million) |
MARKET SIZE 2035 |
390.8(USD Million) |
COMPOUND ANNUAL GROWTH RATE (CAGR) |
9.316% (2025 - 2035) |
REPORT COVERAGE |
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
BASE YEAR |
2024 |
MARKET FORECAST PERIOD |
2025 - 2035 |
HISTORICAL DATA |
2019 - 2024 |
MARKET FORECAST UNITS |
USD Million |
KEY COMPANIES PROFILED |
Gsk Consumer Healthcare, Rakuten, Takeda Pharmaceutical, Sunstar, Daiichi Sankyo, Mitsubishi Tanabe Pharma, Unicharm Corporation, ColgatePalmolive, Procter & Gamble, Kao Corporation, Mitsuya, Shiseido, Lion Corporation, Johnson & Johnson, Amway |
SEGMENTS COVERED |
Indication, Diagnostic Tests, Drug Treatment |
KEY MARKET OPPORTUNITIES |
Increased awareness of oral health, Rise in cosmetic dentistry demand, Growing population in urban areas, Expansion of e-commerce dental products, Development of innovative treatment solutions |
KEY MARKET DYNAMICS |
rising awareness of oral hygiene, increasing disposable income, growing demand for natural treatments, influence of social interactions, expansion of dental clinics |
COUNTRIES COVERED |
Japan |
Frequently Asked Questions (FAQ) :
The Japan Halitosis Treatment Market is expected to be valued at 146.7 million USD in 2024.
In 2035, the Japan Halitosis Treatment Market is projected to reach 390.8 million USD.
The Japan Halitosis Treatment Market is expected to grow at a CAGR of 9.316% from 2025 to 2035.
In 2024, the Gastrointestinal indication holds the largest market value at 35.0 million USD.
By 2035, the market size for the Respiratory indication is expected to reach 80.0 million USD.
Key players include Gsk Consumer Healthcare, Rakuten, Takeda Pharmaceutical, and Sunstar among others.
The projected market value for the Kidney indication in 2035 is 70.0 million USD.
The growth drivers include increasing awareness of oral health and innovative treatment options.
The market for the Liver indication is expected to be valued at 55.0 million USD in 2035.
In 2024, the market size for the Systemic indication is projected to be 36.7 million USD.